Coronavirus vaccines: Pfizer-BioNTech shot likely to foil mutant - New study shows

The BioNTech team is nevertheless ready to adapt the vaccine if needed in the future
The BioNTech team is nevertheless ready to adapt the vaccine if needed in the future